Efamol Launches Efanatal Supplement In UK

17 March 1997

- Efamol will launch its new Efanatal dietary supplement in the UK nextmonth. It comprises the omega-6 long-chain polyunsaturated fatty acid arachidonic acid, as well as gamma linolenic acid, which is converted to AA in the body. The capsule also contains the omega-3 LCP docosahexaenoic acid and the antioxidant vitamin E. The LCP supplement is thought to be important for the healthy development of the brain and eye in the fetus and the breast-fed newborn, and may even augment the child's intelligence, says the company. The product will cost L5.49 ($8.88) for a pack of 30 capsules, a 15-day supply.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight